We are improving the lives of people suffering from mental illness and substance use disorders
What we do
HQ & Pipeline
At the core of a sustainable society
are health and well-being, the areas where
Orexo makes its biggest impact.
MAY 9, 2023
Fentanyl Awareness Day 2023: "Fentanyl is in everything and it’s killing so many people."
APRIL 27, 2023
Orexo Interim Report Q1 2023
APRIL 26, 2023
Presentation of Orexo's Q1 Interim Report 2023 - April 27 at 2 pm
amorphOX® – a versatile drug delivery platform
Orexo’s novel drug delivery platform has unique properties for the development of differentiated pharmaceuticals that need to be absorbed rapidly by the body and remain stable over time.
Press Releases & News
Group net revenues
US Pharma segment EBIT
1 Last Twelve Months, Q222-Q123, for more information about financial development Link
Yesterday CEO Nikolaj Sorensen presented at @ABGSC Life Science Seminar in Sthlm, Sweden. View an excerpt from th… https://t.co/jiXm8elf3R
#Orexo is a commercial stage pharma company. At Erik Penser Bank´s Bolagsdag hosted last week our CEO joined a pane… https://t.co/20sInM1Kgr
Nu kan du lyssna på presentationen på Erik Penser Banks Bolagsdag som hölls förra veckan. Då ESG-frågor blir allt v… https://t.co/WFVe1isvYr